COVID-19Cardiac MRIMyocarditisVaccinemRNA vaccineMyocarditis is an established but rare adverse event following administration of messenger RNA-based coronavirus disease 2019 (COVID-19) vaccines and is most common in male adolescents and young adults. Symptoms typically develop within a few days of ...
Alessandra Buoninfante 1,3 , Arno Andeweg 1,3, Georgy Genov2 & Marco Cavaleri 1 Check for updates Following the start of the COVID-19 vaccination campaign, the adverse events of myocarditis and pericarditis were linked mainly to mRNA COVID-19 vaccines by the regulatory authorities worldwide. ...
While most reported cases of COVID-19 vaccine myocarditis come from large databases of the 2 available mRNA vaccines, the large National English Immunization Database from the UK also showed cases occurring after a non-mRNA-based vaccine (in the period from December 2020 to August 2021). In ...
A study from the Intermountain Heart Institute details the risk of pericarditis and myocarditis associated with COVID-19 vaccines among patients from within their institution's health system. At the American Heart Association (AHA) 2020 Scientific Sessions, much of the discussion related to COVID-19...
which can explain the stronger immune response seen with mRNA vaccines than with other types of COVID-19 vaccine. However, this hypothesis is not supported by the lack of immune-related adverse effects in other organs in which the mRNA vaccine is being uptaken. Molecular mimicry between the sp...
Soon after the first COVID-19 vaccines appeared in 2021, reports ofrare cases of heart inflammation, or myocarditis, began to surface. In most instances, the myocarditis has beenmild and responded well to treatment, though up to four potentially mRNA vaccine-related deaths ...
In myocarditis related to coronavirus disease 2019 (COVID-19), cardiac inflammation is generally due to direct cardiac invasion with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a result of the intense cytokine storm that often arises during the course of the disease.[12] ...
This cohort study examines cardiovascular complications of postvaccine and other types of myocarditis (ie, post–COVID-19 and conventional myocarditis)
can range from asymptomatic to critically ill. Related to severe acute respiratory syndrome-Coronavirus 2 (SARs-CoV-2), children are at greater risk of developing myocarditis secondary to COVID-19 compared to the mRNA COVID-19 vaccine. Diagnosis of myocarditis typically includes laboratory testing,...
A team of Korean researchers recently published the results of a study on histopathologic analysis of myocarditis that occurs after vaccination with Covid-19 vaccines developed by Pfizer and Moderna.Professor Seo Kyung-jin of the Department of Pathology